Sectoral Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Sectoral Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,253,300	Closed	-$5.26M	–	133
2023 Q1	$5.26M	Buy	1,253,300 +273,000	+28%	+$1.42M	1.01%	44
2022 Q4	$5.89M	Buy	980,300 +12,000	+1%	+$65.5K	1.14%	35
2022 Q3	$5.64M	Buy	+968,300	New	+$6.03M	1.11%	37
2018 Q4	–	Sell	-32,241	Closed	-$70K	–	168
2018 Q3	$70K	Buy	+32,241	New	+$79.8K	0.01%	162

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Sectoral Asset Management's CTIC Position: Q2 2023 in Review

Sectoral Asset Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 1,253,300 shares — an estimated $5.26M sold.

Sectoral Asset Management first reported a position in CTIC in Q3 2018 and held it in 4 quarters. The position peaked at $5.89M in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Sectoral Asset Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Sectoral Asset Management sold 1,253,300 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $5.26M.
Sectoral Asset Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2018 and held it in 4 quarters.
Sectoral Asset Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $5.89M in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.